Human-specific staphylococcal virulence factors enhance pathogenicity in a humanised zebrafish C5a receptor model
Buchan, Kyle D.; van Gent, Michiel; Prajsnar, Tomasz K.; Ogryzko, Nikolay V.; de Jong, Nienke W.M.; Kolata, Julia; Foster, Simon J.; van Strijp, Jos A.G.; Renshaw, Stephen A.
(2021) Journal of Cell Science, volume 134, issue 5, pp. 1 - 10
(Article)
Abstract
Staphylococcus aureus infects ∼30% of the human population and causes a spectrum of pathologies ranging from mild skin infections to life-threatening invasive diseases. The strict host specificity of its virulence factors has severely limited the accuracy of in vivo models for the development of vaccines and therapeutics. To resolve this,
... read more
we generated a humanised zebrafish model and determined that neutrophil-specific expression of the human C5a receptor conferred susceptibility to the S. aureus toxins PVL and HlgCB, leading to reduced neutrophil numbers at the site of infection and increased infection-associated mortality. These results show that humanised zebrafish provide a valuable platform to study the contribution of human-specific S. aureus virulence factors to infection in vivo that could facilitate the development of novel therapeutic approaches and essential vaccines.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: Host-pathogen interactions, Immunology, In vivo models, Microbiology, Staphylococcus aureus, Zebrafish, Animals, Humans, Virulence, Receptor, Anaphylatoxin C5a/genetics, Staphylococcus aureus/genetics, Virulence Factors/genetics, Cell Biology, Research Support, Non-U.S. Gov't, Journal Article
ISSN: 0021-9533
Publisher: Company of Biologists Ltd
Note: Funding Information: This work was supported by AMR cross-council funding from the Medical Research Council to the SHIELD consortium ‘Optimising Innate Host Defence to Combat Antimicrobial Resistance’ (MRNO2995X/1), a Medical Research Council (MRC), United Kingdom, programme grant (MR/M004864/1) to S.A.R., and the University of Sheffield 2022 Futures programme via the Florey Institute. T.K.P. was supported by an individual H2020 Marie Skłodowska-Curie Actions fellowship (PIEF-GA-2013-625975). Funding Information: This work was supported by AMR cross-council funding from the Medical Research Council to the SHIELD consortium ?Optimising Innate Host Defence to Combat Antimicrobial Resistance? (MRNO2995X/1), a Medical Research Council (MRC), United Kingdom, programme grant (MR/M004864/1) to S.A.R., and the University of Sheffield 2022 Futures programme via the Florey Institute. T.K.P. was supported by an individual H2020 Marie Sk?odowska-Curie Actions fellowship (PIEF-GA-2013-625975). Publisher Copyright: © 2021. Published by The Company of Biologists Ltd © 2021. Published by The Company of Biologists Ltd.
(Peer reviewed)